GJ Melendez-Torres, Professor of Clinical and Social Epidemiology at the University of Exeter, uses multiple sclerosis to illustrate cost effectiveness in health technology assessment, including benefits beyond outcomes, modeling cost effectiveness, and partitioned survival modes.